Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Free Cash Flow (2021 - 2025)

Historic Free Cash Flow for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.3 million.

  • HeartSciences' Free Cash Flow fell 690.23% to -$2.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$7.5 million, marking a year-over-year increase of 553.37%. This contributed to the annual value of -$7.4 million for FY2025, which is 2088.98% down from last year.
  • Latest data reveals that HeartSciences reported Free Cash Flow of -$2.3 million as of Q4 2025, which was down 690.23% from -$2.0 million recorded in Q3 2025.
  • HeartSciences' 5-year Free Cash Flow high stood at -$717491.0 for Q3 2021, and its period low was -$2.3 million during Q4 2025.
  • Its 5-year average for Free Cash Flow is -$1.5 million, with a median of -$1.6 million in 2025.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 15351.61% in 2022, then surged by 2321.02% in 2025.
  • Quarter analysis of 5 years shows HeartSciences' Free Cash Flow stood at -$768053.0 in 2021, then plummeted by 40.63% to -$1.1 million in 2022, then rose by 8.33% to -$990139.0 in 2023, then crashed by 120.53% to -$2.2 million in 2024, then dropped by 6.9% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q4 2025, -$2.0 million for Q3 2025, and -$1.6 million during Q2 2025.